| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 01/02/2003 | US20030003462 Novel human interleukin-like proteins and polynucleotides encoding them |
| 01/02/2003 | US20030003461 Truncation selex method |
| 01/02/2003 | US20030003460 Microparticles for use as luminesencent tool in bioassays |
| 01/02/2003 | US20030003458 Print head for use in the analysis of preferential paraicles in sample |
| 01/02/2003 | US20030003457 Bio-polymer array system with detection sensitivity enhanced by radiation treatment |
| 01/02/2003 | US20030003456 Method and system of identifying biologically active molecules |
| 01/02/2003 | US20030003455 Stable nucleotide sequences for use as calibration tools in genetic analysis |
| 01/02/2003 | US20030003454 Diagnosing cancer in humans; obtain tissue sample, monitor expression of nucleotide sequences maintanance enzymes, amplified concentration of enzyme indicates cancer |
| 01/02/2003 | US20030003453 DNA molecule encoding a variant paraoxonase and uses thereof |
| 01/02/2003 | US20030003452 Polymerase for use in the treatment of infections, respiratory, blood, alzheimer's, muscular and cancerous disorders |
| 01/02/2003 | US20030003449 Methods and compositions for the determination of protein function and identification of modulators thereof |
| 01/02/2003 | US20030003447 Methods and compositions for modulating the interaction between the APJ receptor and the HIV virus |
| 01/02/2003 | US20030003446 Determination of viral concentration in sample; obtain cell sample, incubate with viricide, detect presence of viral protein, determine concentration of viral proteins |
| 01/02/2003 | US20030003444 R9Detection of preferential polypeptide in sample; obtain sample of polypeptide, incubate with bacteriophage, monitor adjustment in activity, adjustment in activity |
| 01/02/2003 | US20030003443 Designation MVP-5180/91, deposited with the European Collection of Animal Cell Cultures under No V 920 92 318 |
| 01/02/2003 | US20030003442 Retrovirus from the HIV group and its use |
| 01/02/2003 | US20030003102 Morpholino imaging and therapy |
| 01/02/2003 | US20030003101 Treatment and diagnosis of prostate cancer |
| 01/02/2003 | US20030003093 Human beta-alanine-pyruvate aminotransferase |
| 01/02/2003 | US20030003050 Detecting a difference in an untranslated region of mRNA for a gene in which diversity in untranslated region of mRNA affects sensitivity to a drug, and evaluating sensitivity to a drug based on the detected difference |
| 01/02/2003 | US20030000834 Method for analyzing a biological sample |
| 01/02/2003 | EP1271182A2 Stimulable phosphor sheet for detection of substances originating from a living body |
| 01/02/2003 | EP1271153A2 Collapsin response mediator protein-1 as tumor metastasis marker |
| 01/02/2003 | EP1271149A2 Structure with immobilized biological material and method for manufacturing the same |
| 01/02/2003 | EP1271146A1 Method and composition of cellular reprogramming |
| 01/02/2003 | EP1271145A1 Methods and cell populations for identifying and validating genomic targets, and for drug screening |
| 01/02/2003 | EP1270745A2 Thymosin B15 as a marker in diagnosis and prognosis of cancer |
| 01/02/2003 | EP1270744A1 Reporter gene construct for the detection of HIV rev and HIV tat |
| 01/02/2003 | EP1270743A2 Method for radioactive detection of hybridized nucleic acids involving a partitioned composite membrane comprising porous material portions, e.g., nylon, and a stimulable phosphor layer |
| 01/02/2003 | EP1270741A1 Nucleotide sequences involved in plant disease resistance |
| 01/02/2003 | EP1270740A1 Biochip and its use for determining inflammation |
| 01/02/2003 | EP1270739A1 Engineered secreted alkaline phosphatase (seap) reporter genes and polypeptides |
| 01/02/2003 | EP1270738A1 Method for detecting substances in liquids |
| 01/02/2003 | EP1270737A1 Preincubation assay method |
| 01/02/2003 | EP1270736A1 Films for assaying protease activity |
| 01/02/2003 | EP1270732A1 Improved transfection of eukaryontic cells with linear polynucleotides by electroporation |
| 01/02/2003 | EP1270715A1 System and method for optically monitoring the concentration of a gas in a sample vial using photothermal spectroscopy to detect sample growth |
| 01/02/2003 | EP1270594A1 Antibodies to peptide from a soluble fragment of acetylcholinesterase |
| 01/02/2003 | EP1270591A1 Transgenic cells and a method for detecting disruptors for androgens by using said transgenic cells |
| 01/02/2003 | EP1270588A1 Novel collagen-like protein clac, precursor thereof and genes encoding the same |
| 01/02/2003 | EP1270586A2 Composition for the cell-specific transfer of active substances |
| 01/02/2003 | EP1270044A2 Wound healing biomarkers |
| 01/02/2003 | EP1270015A2 A complex comprising OCIF and Polysaccharide |
| 01/02/2003 | EP1269200A2 Method for prediction of preeclampsia and other diseases |
| 01/02/2003 | EP1269199A2 Methods involving induced dimerisation by cellular components |
| 01/02/2003 | EP1269198A2 Identification of mast/basophil activation inhibitors |
| 01/02/2003 | EP1269197A2 Detection of nerve damage using marker scip |
| 01/02/2003 | EP1269193A2 A lysosomal pepstatin-insensitive proteinase as biomarker for breast cancer |
| 01/02/2003 | EP1269192A1 Biotin-peg-substrate for a lipase assay |
| 01/02/2003 | EP1269191A1 Docosahexaenoic acid as retinoid x receptor and uses thereof |
| 01/02/2003 | EP1269190A2 Method for detecting and/or quantifying first molecules |
| 01/02/2003 | EP1269187A1 Function homology screening |
| 01/02/2003 | EP1269183A1 Assay for agents that induce chemokinesis |
| 01/02/2003 | EP1269180A1 Methods for screening and identifying pathogen virulence factors |
| 01/02/2003 | EP1269173A2 Rapid response glucose sensor |
| 01/02/2003 | EP1268861A2 Diagnosis of diseases associated with dna transcription |
| 01/02/2003 | EP1268860A1 Patient stratification for cancer therapy based on genomic dna microarray analysis |
| 01/02/2003 | EP1268859A2 Methods for genotyping by hybridization analysis |
| 01/02/2003 | EP1268858A1 Use of particles which have signal-emitting characteristics and at least one group with an affinity for marked nucleic acids |
| 01/02/2003 | EP1268857A2 Diagnosis of diseases associated with gene regulation |
| 01/02/2003 | EP1268856A2 Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations |
| 01/02/2003 | EP1268855A2 Diagnosis of diseases associated with tumor suppressor genes and oncogenes |
| 01/02/2003 | EP1268854A1 High specificity marker detection |
| 01/02/2003 | EP1268853A2 A process to determine heterozygote genomic dna duplication and deletion |
| 01/02/2003 | EP1268852A1 Use of a mutation in the gene for the beta-3-subunit of human g-protein |
| 01/02/2003 | EP1268851A1 Method of concentrating and recovering a viral enzyme activity from biological samples |
| 01/02/2003 | EP1268850A1 Fluorescence detection of proteases or peptidases |
| 01/02/2003 | EP1268849A2 Reagents and methods for detecting a reduced cofactor |
| 01/02/2003 | EP1268848A2 Monooxygenase assays |
| 01/02/2003 | EP1268847A2 Ubiquitin ligase assay |
| 01/02/2003 | EP1268846A1 Diagnosis of autoimmune disease |
| 01/02/2003 | EP1268845A2 Cell-free reconstitution of autophagocytosis |
| 01/02/2003 | EP1268844A1 Modulating production of pneumococcal capsular polysaccharide |
| 01/02/2003 | EP1268843A1 A systematic approach to the analysis of gene function |
| 01/02/2003 | EP1268842A1 Improved reverse n-hybrid screening method |
| 01/02/2003 | EP1268841A2 Detection of viable agents |
| 01/02/2003 | EP1268835A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 01/02/2003 | EP1268827A2 Methods of selection and development of plants having improved root quality and root lodging resistance |
| 01/02/2003 | EP1268820A2 Estrogen-regulated myo-inositol phosphate synthase: compositions and methods of use |
| 01/02/2003 | EP1268817A1 Human pyruvate dehydrogenese phosphatase |
| 01/02/2003 | EP1268816A2 Calcium-binding regulatory subunit |
| 01/02/2003 | EP1268802A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 01/02/2003 | EP1268800A2 Mucin-1 specific binding members and methods of use thereof |
| 01/02/2003 | EP1268797A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/02/2003 | EP1268796A1 Identification of human gaba transporter |
| 01/02/2003 | EP1268793A2 Fibroblast growth factor receptor-like molecules and uses thereof |
| 01/02/2003 | EP1268792A2 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 01/02/2003 | EP1268791A2 Brca-1 regulators and methods of use |
| 01/02/2003 | EP1268790A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
| 01/02/2003 | EP1268788A2 Aryl propenal double bond reductase |
| 01/02/2003 | EP1268785A2 Gtp-binding protein gamma-12 subunit |
| 01/02/2003 | EP1268784A2 Genes involved in intestinal inflammatory diseases and use thereof |
| 01/02/2003 | EP1268781A2 G12l, a gene associated with the thermal response |
| 01/02/2003 | EP1268778A1 Materials and methods relating to a novel splice variant of a na + dependent glutamate transporter |
| 01/02/2003 | EP1268775A1 The high bone mass gene of 11q13.3 |
| 01/02/2003 | EP1268774A2 Identification of essential genes in prokaryotes |
| 01/02/2003 | EP1268772A2 Peptide and nucleic acid coding therefor for the detection, diagnosis and therapy of diseases of the nervous system |
| 01/02/2003 | EP1268768A2 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 01/02/2003 | EP1268767A2 Methods and compositions for elucidating protein expression profiles in cells |
| 01/02/2003 | EP1268766A2 Improvements to ribosome display |